2 completed, 2 terminated. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Terminated 1 |
Follow DiObex: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients DIO-902 - Type 2 Diabetes | Phase 2 / Phase 3 | Terminated | DiObex | 150 | 2008-01-01 | 2008-05-28 |
| A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes DIO-902, DIO-902 placebo - Type 2 Diabetes | Phase 2 | Terminated | DiObex | 200 | 2007-07-01 | 2008-11-13 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus very low dose (VLD) glucagon - Type 1 Diabetes | Phase 1 | Completed | DiObex | 10 | 2006-03-01 | 2006-08-23 |
| A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus 2S, 4R Ketoconazole (DIO-902) - Type 2 Diabetes | Phase 1 / Phase 2 | Completed | DiObex | 50 | 2005-02-01 | 2008-02-22 |
Diabetes Mellitus (3) · Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus, Type 1 (1)
Glucagon (1)
United States (4) · Australia (2) · New Zealand (2)
Sherwin Schwartz, MD (1) · Sherwyn Schwartz, MD (1) · Steven Edelman, MD (1)